Cellular Tumor Antigen p53 Market

Cellular Tumor Antigen p53 Market contains market size and forecasts of Cellular Tumor Antigen p53 in global, including the following market information:
Global Cellular Tumor Antigen p53 Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cellular Tumor Antigen p53 Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Cellular Tumor Antigen p53 companies in 2021 (%)
The global Cellular Tumor Antigen p53 market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
COTI-2 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cellular Tumor Antigen p53 include Advaxis, Inc., American Gene Technologies International Inc., Aprea AB, Cellceutix Corporation, Critical Outcome Technologies Inc., Eleos Inc., ORCA Therapeutics B.V., OSE Pharma SA and PCI Biotech Holding ASA, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cellular Tumor Antigen p53 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cellular Tumor Antigen p53 Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Cellular Tumor Antigen p53 Market Segment Percentages, by Type, 2021 (%)
COTI-2
D-12PGJ3
APR-246
ATRN-502
Cenersen Sodium
MJ-05
MX-225
Others
Global Cellular Tumor Antigen p53 Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Cellular Tumor Antigen p53 Market Segment Percentages, by Application, 2021 (%)
Ovarian Cancer
Prostate Cancer
Brain Cancer
Others
Global Cellular Tumor Antigen p53 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Cellular Tumor Antigen p53 Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cellular Tumor Antigen p53 revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cellular Tumor Antigen p53 revenues share in global market, 2021 (%)
Key companies Cellular Tumor Antigen p53 sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Cellular Tumor Antigen p53 sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Advaxis, Inc.
American Gene Technologies International Inc.
Aprea AB
Cellceutix Corporation
Critical Outcome Technologies Inc.
Eleos Inc.
ORCA Therapeutics B.V.
OSE Pharma SA
PCI Biotech Holding ASA
Quark Pharmaceuticals, Inc.
Stemline Therapeutics, Inc.
Shenzen SiBiono GeneTech Co., Ltd.
SK Biopharmaceuticals Co., Ltd.
Tara Immuno-Oncology Therapeutics LLC
Z53 Therapeutics, LLC